Journals of the American College of Cardiology

• Wearable Health and Fitness Tech in Cardiovascular Medicine This review examines the various cardiovascular metrics provided by common consumer wearable devices. What are the potential pitfalls in interpreting and evaluating these metrics?
  Journal of the American College of Cardiology, September 04, 2023
• Single Troponin Measurement to Rule Out Myocardial Infarction This review focuses on the potential benefits and limitations of a single-sample high-sensitivity cardiac troponin assay taken in the emergency department in order to exclude acute MI.
  Journal of the American College of Cardiology, August 21, 2023
• Gut Microbiome in Cardiovascular Disease and Heart Failure A new study investigates the relevance of imidazole propionate, a gut microbial metabolite, to cardiovascular disease and heart failure.
  JACC: Heart Failure, August 14, 2023
• Alcohol and Neural Network Activity A new study suggests a novel underlying mechanism for the protective effect of moderate alcohol consumption on cardiovascular health.
  Journal of the American College of Cardiology, July 27, 2023
• How to Manage Heart Failure With Preserved Ejection Fraction This review provides an up-to-date framework for diagnosis and evidence-based treatment of patients with heart failure with preserved ejection fraction.
  JACC: Heart Failure, July 24, 2023
• Single-Point Vulnerabilities in Atherosclerotic Plaque A new study incorporates spatial analysis into investigations of human plaque pathophysiology to determine how pathogenic mechanisms of plaque rupture operate.
  Journal of the American College of Cardiology, July 20, 2023
• Clonal Hematopoiesis in Patients With ASCVD A new study provides strong evidence of the significant clinical impact of clonal hematopoiesis of indeterminate potential in patients with atherosclerotic cardiovascular disease.
  Journal of the American College of Cardiology, July 10, 2023
• Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime? A new study aims to elucidate the relationship of plasma Lp(a) and oxidized phospholipids to acute coronary events. Could targeting OxPLs directly be an approach to reducing CVD associated with Lp(a)?
  Journal of the American College of Cardiology, July 03, 2023
• Lipid-Lowering Therapy in the Elderly: Are Guidelines Ageist? Are patients 75 and older being inadequately treated with statin therapy based on current guidelines?
  Journal of the American College of Cardiology, June 26, 2023
• How to Make the Transplantation Allocation System Better In this commentary, the authors highlight shortcomings of the current transplantation allocation system and propose a new modeling strategy to improve equitable access to transplantation.
  JACC: Heart Failure, June 19, 2023
• Detection of Vulnerable Plaque With Intravascular Imaging According to this commentary, a new study conclusively demonstrates that optical coherence tomography as well as other noninvasive imaging modalities are capable of detecting vulnerable plaque.
  Journal of the American College of Cardiology, June 19, 2023
• Nonthrombogenic Roles of the Left Atrial Appendage Does the left atrial appendage have important nonthrombogenic roles? This paper discusses recent studies which demonstrate other functions of the LAA, with potential therapeutic implications.
  Journal of the American College of Cardiology, June 05, 2023
• Sudden Cardiac Death Among Adolescents in the United Kingdom This study investigated various etiologies of sudden cardiac death and their association with physical activity in a large cohort of adolescents, both athletes and non-athletes.
  Journal of the American College of Cardiology, May 22, 2023
• Bleeding Events After Transcatheter Aortic Valve Replacement This review provides an in-depth overview of bleeding events after TAVR and their clinical impact, as well as antithrombotic management and its potential influence on bleeding complications.
  Journal of the American College of Cardiology, May 15, 2023
• Medication-Attributable Adverse Events in Heart Failure Trials How often are adverse events in heart failure patients actually attributable to guideline-directed medical therapies, as opposed to a manifestation of HFrEF itself or other comorbidities?
  JACC: Heart Failure, May 15, 2023
• Cardiovascular Evaluation and Management of Obese Patients This paper examines the unique clinical challenges which accompany the diagnosis and treatment of cardiovascular disease in persons who are overweight or obese.
  Journal of the American College of Cardiology, May 08, 2023
• Elevated LDL Triglycerides and Atherosclerotic Risk Are low-density lipoprotein triglycerides associated with an increased risk of atherosclerotic cardiovascular disease?
  Journal of the American College of Cardiology, May 01, 2023
• Is Dapagliflozin a Cardiac Anti-Aging Drug? A new study elucidates the mechanisms behind the beneficial effects of dapagliflozin in the cardiovascular system. Might it have an anti-aging effect?
  JACC: Heart Failure, May 01, 2023
• Should We Reject Dietary Supplements for Reducing LDL-C? This commentary addresses whether selected dietary supplements, particularly plant sterols or stanols and soluble fibers, should be promoted as lowering LDL cholesterol.
  Journal of the American College of Cardiology, April 24, 2023
• HFpEF: An Explanation for Unexplained Dyspnea This commentary highlights the need for early diagnosis of HFpEF and its prevalence in patients with unexplained dyspnea.
  JACC: Heart Failure, April 21, 2023